http://www.raredr.com/videos/which-patients-gaucher-switching-cerdelga
Which Patients with Gaucher Disease Are Switching to the Oral Treatment Option?




Barry Rosenbloom, MD, Cedar Sinai Medical Center talks about the type of patients with Gaucher disease who are most likely to switch from intravenous enzyme replacement therapy to the new oral treatment option - Cerdelga (eliglustat).
Printer Printing...
$content$